Related Experiment Video

Updated: Jun 24, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Kinetic dependence of paramyxovirus entry inhibition

Matteo Porotto1, Christine C Yokoyama, Gianmarco Orefice

  • 1Department of Pediatrics, Weill Medical College of Cornell University, New York, New York 10021, USA.

Journal of Virology
|April 17, 2009
PubMed

Insights

Inhibitory peptides targeting paramyxovirus fusion proteins are less effective when the virus activates fusion faster. Understanding fusion kinetics is crucial for developing effective antiviral fusion inhibitors.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Paramyxovirus fusion (F) proteins mediate viral entry by forming a six-helix bundle structure.
  • Peptides targeting conserved heptad repeat (HR) regions can inhibit this fusion process.
  • Current strategies focus on peptide binding affinity to the target HR region.

Purpose of the Study:

  • To investigate additional factors influencing the efficacy of peptide-based fusion inhibitors.
  • To explore the role of viral fusion activation kinetics in peptide effectiveness.
  • To identify new considerations for developing antiviral fusion inhibitors.

Main Methods:

  • Analysis of peptide interactions with paramyxovirus F proteins.
  • Kinetic studies of F protein activation by attachment proteins.
  • Modulation of peptide efficacy based on fusion activation rates.

Main Results:

  • Peptide efficacy depends not only on binding affinity but also on the kinetics of F protein activation.
  • Rapid F protein activation by attachment proteins shortens the window for inhibitory peptides to act.
  • This kinetic modulation significantly impacts the overall effectiveness of fusion inhibitors.

Conclusions:

  • Fusion activation kinetics represent a critical, previously underappreciated factor in peptide inhibitor efficacy.
  • Developing effective fusion inhibitors requires consideration of both binding affinity and the dynamics of viral fusion.
  • These findings offer new insights for designing next-generation paramyxovirus antiviral strategies.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation07:24

In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation

Published on: March 27, 2016

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a virus that...